183 related articles for article (PubMed ID: 34181691)
1. The endogenous cellular protease inhibitor SPINT2 controls SARS-CoV-2 viral infection and is associated to disease severity.
Ramirez Alvarez C; Kee C; Sharma AK; Thomas L; Schmidt FI; Stanifer ML; Boulant S; Herrmann C
PLoS Pathog; 2021 Jun; 17(6):e1009687. PubMed ID: 34181691
[TBL] [Abstract][Full Text] [Related]
2. Priming of SARS-CoV-2 S protein by several membrane-bound serine proteinases could explain enhanced viral infectivity and systemic COVID-19 infection.
Fuentes-Prior P
J Biol Chem; 2021; 296():100135. PubMed ID: 33268377
[TBL] [Abstract][Full Text] [Related]
3. The Physiological TMPRSS2 Inhibitor HAI-2 Alleviates SARS-CoV-2 Infection.
Tomita Y; Matsuyama S; Fukuhara H; Maenaka K; Kataoka H; Hashiguchi T; Takeda M
J Virol; 2021 May; 95(12):. PubMed ID: 33789993
[No Abstract] [Full Text] [Related]
4. Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
Essalmani R; Jain J; Susan-Resiga D; Andréo U; Evagelidis A; Derbali RM; Huynh DN; Dallaire F; Laporte M; Delpal A; Sutto-Ortiz P; Coutard B; Mapa C; Wilcoxen K; Decroly E; Nq Pham T; Cohen ÉA; Seidah NG
J Virol; 2022 Apr; 96(8):e0012822. PubMed ID: 35343766
[TBL] [Abstract][Full Text] [Related]
5. Prostate adenocarcinoma and COVID-19: The possible impacts of TMPRSS2 expressions in susceptibility to SARS-CoV-2.
Cheng J; Zhou J; Fu S; Fu J; Zhou B; Chen H; Fu J; Wei C
J Cell Mol Med; 2021 Apr; 25(8):4157-4165. PubMed ID: 33609069
[TBL] [Abstract][Full Text] [Related]
6. TMPRSS2 expression dictates the entry route used by SARS-CoV-2 to infect host cells.
Koch J; Uckeley ZM; Doldan P; Stanifer M; Boulant S; Lozach PY
EMBO J; 2021 Aug; 40(16):e107821. PubMed ID: 34159616
[TBL] [Abstract][Full Text] [Related]
7. Structural Basis of Covalent Inhibitory Mechanism of TMPRSS2-Related Serine Proteases by Camostat.
Sun G; Sui Y; Zhou Y; Ya J; Yuan C; Jiang L; Huang M
J Virol; 2021 Sep; 95(19):e0086121. PubMed ID: 34160253
[TBL] [Abstract][Full Text] [Related]
8. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
Li K; Meyerholz DK; Bartlett JA; McCray PB
mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
[TBL] [Abstract][Full Text] [Related]
9. Targeting the intestinal TMPRSS2 protease to prevent SARS-CoV-2 entry into enterocytes-prospects and challenges.
Mahmoud IS; Jarrar YB
Mol Biol Rep; 2021 May; 48(5):4667-4675. PubMed ID: 34023987
[TBL] [Abstract][Full Text] [Related]
10. Covid-19 pathogenesis in prostatic cancer and TMPRSS2-ERG regulatory genetic pathway.
Afshari A; Janfeshan S; Yaghobi R; Roozbeh J; Azarpira N
Infect Genet Evol; 2021 Mar; 88():104669. PubMed ID: 33301988
[TBL] [Abstract][Full Text] [Related]
11. Co-expression of the SARS-CoV-2 entry molecules ACE2 and TMPRSS2 in human ovaries: Identification of cell types and trends with age.
Wu M; Ma L; Xue L; Zhu Q; Zhou S; Dai J; Yan W; Zhang J; Wang S
Genomics; 2021 Nov; 113(6):3449-3460. PubMed ID: 34418496
[TBL] [Abstract][Full Text] [Related]
12. ILRUN Downregulates ACE2 Expression and Blocks Infection of Human Cells by SARS-CoV-2.
Tribolet L; Alexander MR; Brice AM; van Vuren PJ; Rootes CL; Mara K; McDonald M; Bruce KL; Gough TJ; Shi S; Cowled C; Bean AGD; Stewart CR
J Virol; 2021 Jul; 95(15):e0032721. PubMed ID: 33963054
[TBL] [Abstract][Full Text] [Related]
13. Serine Protease Inhibitors Restrict Host Susceptibility to SARS-CoV-2 Infections.
Rosendal E; Mihai IS; Becker M; Das D; Frängsmyr L; Persson BD; Rankin GD; Gröning R; Trygg J; Forsell M; Ankarklev J; Blomberg A; Henriksson J; Överby AK; Lenman A
mBio; 2022 Jun; 13(3):e0089222. PubMed ID: 35532162
[TBL] [Abstract][Full Text] [Related]
14. The Transmembrane Protease TMPRSS2 as a Therapeutic Target for COVID-19 Treatment.
Wettstein L; Kirchhoff F; Münch J
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163273
[TBL] [Abstract][Full Text] [Related]
15. Transmembrane serine protease TMPRSS2 implicated in SARS-CoV-2 infection is autoactivated intracellularly and requires N-glycosylation for regulation.
Zhang Y; Sun S; Du C; Hu K; Zhang C; Liu M; Wu Q; Dong N
J Biol Chem; 2022 Dec; 298(12):102643. PubMed ID: 36309092
[TBL] [Abstract][Full Text] [Related]
16. d-Galactose treatment increases ACE2, TMPRSS2, and FURIN and reduces SERPINA1 mRNA expression in A549 human lung epithelial cells.
Baristaite G; Gurwitz D
Drug Dev Res; 2022 May; 83(3):622-627. PubMed ID: 34677831
[TBL] [Abstract][Full Text] [Related]
17. ACE2, TMPRSS2, and Furin variants and SARS-CoV-2 infection in Madrid, Spain.
Torre-Fuentes L; Matías-Guiu J; Hernández-Lorenzo L; Montero-Escribano P; Pytel V; Porta-Etessam J; Gómez-Pinedo U; Matías-Guiu JA
J Med Virol; 2021 Feb; 93(2):863-869. PubMed ID: 32691890
[TBL] [Abstract][Full Text] [Related]
18. SPINT2 inhibits proteases involved in activation of both influenza viruses and metapneumoviruses.
Straus MR; Kinder JT; Segall M; Dutch RE; Whittaker GR
Virology; 2020 Apr; 543():43-53. PubMed ID: 32056846
[TBL] [Abstract][Full Text] [Related]
19. Spiking dependence of SARS-CoV-2 pathogenicity on TMPRSS2.
Abbasi AZ; Kiyani DA; Hamid SM; Saalim M; Fahim A; Jalal N
J Med Virol; 2021 Jul; 93(7):4205-4218. PubMed ID: 33638460
[TBL] [Abstract][Full Text] [Related]
20. A Novel Glucocorticoid and Androgen Receptor Modulator Reduces Viral Entry and Innate Immune Inflammatory Responses in the Syrian Hamster Model of SARS-CoV-2 Infection.
Rocha SM; Fagre AC; Latham AS; Cummings JE; Aboellail TA; Reigan P; Aldaz DA; McDermott CP; Popichak KA; Kading RC; Schountz T; Theise ND; Slayden RA; Tjalkens RB
Front Immunol; 2022; 13():811430. PubMed ID: 35250984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]